Self-regulating diabetes implant could act as a tiny pancreas
TL;DR
A Technion-led team, collaborating with MIT, Harvard, and others, reports a living, cell-based implant that functions as a pancreas by sensing glucose and producing insulin within the device, protected from immune attack by a crystalline shield; tested in animals, it aims to provide a self-regulating diabetes treatment and may be adaptable to other chronic diseases, but human trials have not yet begun.
- New implant could transform diabetes treatment The Jerusalem Post
- Israeli‑led research unveils 'living' implant that could end insulin shots ynetnews
- Self-regulating living implant could end daily insulin injections Medical Xpress
- Beta cell therapy breakthrough and the harm of weight stigma: January 2026 research highlights Diabetes UK
- Israeli Implant Could Replace Insulin Shots IFCJ
Want the full story? Read the original reporting
Read on The Jerusalem Post